Survival of older patients with advanced biliary tract cancers by disease site.

被引：0
|
作者：
Bobiak, Sarah
Lubeck, Deborah P.
Duryea, Jennifer
Danese, Mark D.
机构：
[1] EMD Serono Res & Dev Inst Inc, Billerica, MA USA
[2] Outcomes Insights Inc, Westlake Village, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16598
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Skeletal muscle status and survival among patients with advanced biliary tract cancer
    Takaoka, Shinya
    Hamada, Tsuyoshi
    Takahara, Naminatsu
    Saito, Kei
    Endo, Go
    Hakuta, Ryunosuke
    Ishida, Kota
    Ishigaki, Kazunaga
    Kanai, Sachiko
    Kurihara, Kohei
    Oyama, Hiroki
    Saito, Tomotaka
    Sato, Tatsuya
    Suzuki, Tatsunori
    Suzuki, Yukari
    Tange, Shuichi
    Tokito, Yurie
    Tateishi, Ryosuke
    Nakai, Yousuke
    Fujishiro, Mitsuhiro
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (03) : 248 - 257
  • [32] Addition of an antiangiogenic therapy, bevacizumab, to gemcitabine plus oxaliplatin improves survival in advanced biliary tract cancers
    Marie Bréchon
    Marie Dior
    Johann Dréanic
    Bertrand Brieau
    Marie-Anne Guillaumot
    Catherine Brezault
    Olivier Mir
    François Goldwasser
    Romain Coriat
    [J]. Investigational New Drugs, 2018, 36 : 156 - 162
  • [33] Skeletal muscle status and survival among patients with advanced biliary tract cancer
    Shinya Takaoka
    Tsuyoshi Hamada
    Naminatsu Takahara
    Kei Saito
    Go Endo
    Ryunosuke Hakuta
    Kota Ishida
    Kazunaga Ishigaki
    Sachiko Kanai
    Kohei Kurihara
    Hiroki Oyama
    Tomotaka Saito
    Tatsuya Sato
    Tatsunori Suzuki
    Yukari Suzuki
    Shuichi Tange
    Yurie Tokito
    Ryosuke Tateishi
    Yousuke Nakai
    Mitsuhiro Fujishiro
    [J]. International Journal of Clinical Oncology, 2024, 29 : 297 - 308
  • [34] Second-line therapies in advanced biliary tract cancers
    Tella, Sri Harsha
    Kommalapati, Anuhya
    Borad, Mitesh J.
    Mahipal, Amit
    [J]. LANCET ONCOLOGY, 2020, 21 (01): : E29 - E41
  • [35] Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers
    Verderame, F.
    Russo, A.
    Di Leo, R.
    Badalamenti, G.
    Santangelo, D.
    Cicero, G.
    Valerio, M. R.
    Gulotta, G.
    Tomasello, G.
    Gebbia, N.
    Fulfaro, F.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : VII68 - VII72
  • [36] Systemic chemotherapy for advanced biliary tract cancers: present and future
    Malka, D.
    Boige, V.
    Ducreux, M.
    [J]. ONCOLOGIE, 2010, 12 (10) : 623 - 628
  • [37] Quality of Life and Symptom Management in Advanced Biliary Tract Cancers
    Hunter, Lindsay A.
    Soares, Heloisa P.
    [J]. CANCERS, 2021, 13 (20)
  • [38] Circulating Tumor DNA Profiling of Advanced Biliary Tract Cancers
    Mody, Kabir
    Kasi, Pashtoon M.
    Yang, JuDong
    Surapaneni, Phani Keerthi
    Bekaii-Saab, Tanios
    Ahn, Daniel H.
    Mahipal, Amit
    Sonbol, Mohamad B.
    Starr, Jason S.
    Roberts, Ali
    Nagy, Rebecca
    Lanman, Richard
    Borad, Mitesh J.
    [J]. JCO PRECISION ONCOLOGY, 2019, 3 : 1 - 9
  • [39] Risk and Surveillance of Cancers in Primary Biliary Tract Disease
    Hrad, Valery
    Abebe, Yoftahe
    Ali, Syed Haris
    Velgersdyk, Jared
    Al Hallak, Mohammed
    Imam, Mohamad
    [J]. GASTROENTEROLOGY RESEARCH AND PRACTICE, 2016, 2016
  • [40] Use, response and outcomes of second-line chemotherapy in patients with advanced biliary tract cancers
    Mathers, Brittney
    Abadi, Shirin
    Davies, Janine M.
    McIntyre, Connor
    Ho, Cheryl
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, : 1381 - 1386
12345